Haemolysed sample identification in BA/BE study and others [Regulatives / Guidelines]

posted by vish14184 – India, 2018-05-09 19:43 (2972 d 23:37 ago) – Posting: # 18759
Views: 3,236

Dear all,

Please share your experience/view on below points. Thank you in advance.

1. Is it acceptable regulatory point of view (AnVIsa, EMA), If we identify haemolysed samples with it's grade (severe, moderate, slightly) during sample receipt in bioanalytical lab instead of haemolysed sample identification at clinical stage during sample separation as per defined procedure in SOP.

2. As per ANVISA requirements: is it required to evaluate ECG by cardiologist in BA/BE Study or ECG evaluation by medical qualified person is acceptable?

3. What is x-ray validity is acceptable for BA/BE Study? One year is acceptable if Ethics committee approving it.

Thank you

With regards
Vishal

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
322 visitors (0 registered, 322 guests [including 16 identified bots]).
Forum time: 19:20 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5